Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the ‘hygiene hypothesis’?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the ‘hygiene hypothesis’?
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROLOGY
Volume 25, Issue 7, Pages 925-933
Publisher
Wiley
Online
2018-03-12
DOI
10.1111/ene.13622
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody-Dependent NK Cell Activation Differentially Targets EBV-Infected Cells in Lytic Cycle and Bystander B Lymphocytes Bound to Viral Antigen–Containing Particles
- (2017) María López-Montañés et al. JOURNAL OF IMMUNOLOGY
- Immune Checkpoint Function of CD85j in CD8 T Cell Differentiation and Aging
- (2017) Claire E. Gustafson et al. Frontiers in Immunology
- Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation
- (2017) Marjan Vanheusden et al. Scientific Reports
- Dichotomous effects of latent CMV infection on the phenotype and functional properties of CD8+ T-cells and NK-cells
- (2016) Austin B. Bigley et al. CELLULAR IMMUNOLOGY
- Antibody-Mediated Response of NKG2CbrightNK Cells against Human Cytomegalovirus
- (2015) Marcel Costa-Garcia et al. JOURNAL OF IMMUNOLOGY
- Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis
- (2015) Jose E Martínez-Rodríguez et al. Multiple Sclerosis Journal
- Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination
- (2015) Naila Makhani et al. Multiple Sclerosis Journal
- Cytomegalovirus: a culprit or protector in multiple sclerosis?
- (2015) Marjan Vanheusden et al. TRENDS IN MOLECULAR MEDICINE
- Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis
- (2015) Jose E Martínez-Rodríguez et al. Multiple Sclerosis Journal
- Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination
- (2015) Naila Makhani et al. Multiple Sclerosis Journal
- Heterologous immunity between viruses
- (2015) Raymond M. Welsh et al. IMMUNOLOGICAL REVIEWS
- New advances in CMV and immunosenescence
- (2014) Paolo Sansoni et al. EXPERIMENTAL GERONTOLOGY
- Bystander Chronic Infection Negatively Impacts Development of CD8+ T Cell Memory
- (2014) Erietta Stelekati et al. IMMUNITY
- The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection
- (2014) Miguel López-Botet et al. SEMINARS IN IMMUNOLOGY
- Evidence linking HHV-6 with multiple sclerosis: an update
- (2014) Emily C Leibovitch et al. Current Opinion in Virology
- Human Cytomegalovirus and Autoimmune Disease
- (2014) Anne Halenius et al. Biomed Research International
- Cytomegalovirus seropositivity is negatively associated with multiple sclerosis
- (2013) E Sundqvist et al. Multiple Sclerosis Journal
- T Cell Receptor Diversity Inversely Correlates with Pathogen-Specific Antibody Levels in Human Cytomegalovirus Infection
- (2012) G. C. Wang et al. Science Translational Medicine
- Hygiene Hypothesis and Autoimmune Diseases
- (2011) Graham A. W. Rook CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Immune modulation during latent herpesvirus infection
- (2011) Douglas W. White et al. IMMUNOLOGICAL REVIEWS
- Common viruses associated with lower pediatric multiple sclerosis risk
- (2011) E. Waubant et al. NEUROLOGY
- Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis
- (2009) Jan D. Lünemann et al. ANNALS OF NEUROLOGY
- Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
- (2008) Samantha Jilek et al. BRAIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started